Synthesis of 2-Amino Muramyl Dipeptide Derivatives

Technology

Our innate immune system must recognize and destroy harmful bacteria while maintaining the proper balance of commensal bacteria. Muramyl dipeptide (MDP) is a peptidoglycan (PG) constituent of both the Gram-positive and Gram-negative bacteria. PG is constructed from peptides and two monosaccargide unites although the peptides can vary the monosaccharide remain constant. One of the monosaccahirdies is N-acetyl-muramic acid (NAM). The inventive concept here is described as an efficient and high-yielding method for the synthetic production of NAM derivatives. PG fragments such as N-acteyl muramyl dipeptide (MDP) are highly conserved and this fragment has been shown to be the smallest bacterial cell wall fragment to activate an immune response via the Nod2 innate immune receptor. This functional activity makes MDP a widely used vaccine adjuvant. However it is not known how these PG fragments modulate the Nod2 receptor. This invention would allow biological studies to be investigated. This process can also be used for the preparation of fluorophore (“flash lights”), biotinylated and isotopically labeled versions of NAM which are highly applicable in biological studies (see Melnyk, J. E. et al. J. Am. Chem. Soc. 2015, 137, 22, 6987). These derivatives may be used as the building blocks for making PGs in vitro or in vivo which can be used to modify the cell wall of bacterial cells or modulate the innate immune response. Suitable for fluorescent labeling of peptidoglycans when ‘click’-conjugated to a fluorescent dye.

Benefits

  • The process assists with human immune recognition and targeting antibiotics to the protective coat of a cell (peptidoglycan- PG) through an install/delivery of NAM probes to the carbohydrate wall of negative bacteria.
  • The process allows for a robust method to generate NAM derivatives.
  • The process allows for the synthesis of fluorophore (flash lights/probes), biotinylated and isotopically labelled versions of NAM to label the bacteria.

Applications

  • Can be used by pharmaceutical companies for biological studies of the mechanism of action of MDP and derivatives of MDP, advancing the use of MDP as a vaccine adjuvant.

Additional info

This technology is available for licensing and has fully preserved U.S. patent rights #10,988,508.